Verition Fund Management’s Translational Development Acquisition Corp TDAC Stock Holding History
Bought
Maintained
Sold
Other funds holding TDAC
MF
WAM
AA
LP
TCM
KIM
PAMP
AIMCA
LA
Verition Fund Management's TDAC Position: Q1 2026 in Review
Verition Fund Management reduced its Translational Development Acquisition Corp (TDAC) stake by 12% in Q1 2026, selling an estimated $236K and leaving 169,103 shares worth $1.79M. The position accounts for 0.01% of the portfolio, ranked #1081.
Verition Fund Management first reported a position in TDAC in Q1 2025 and has held it in 5 quarters since. The position peaked at $2.18M in Q1 2025. 48 funds tracked by Wall St. Rank hold TDAC as of Q1 2026.
- Verition Fund Management held 169,103 shares of Translational Development Acquisition Corp worth $1.79M as of Q1 2026.
- Verition Fund Management sold 22,432 Translational Development Acquisition Corp shares in Q1 2026, an estimated $236K.
- Translational Development Acquisition Corp made up 0.01% of Verition Fund Management's portfolio in Q1 2026, its #1081 holding.
- Verition Fund Management first reported a position in Translational Development Acquisition Corp in Q1 2025 and has held it in 5 quarters since.
- Verition Fund Management's Translational Development Acquisition Corp position peaked at $2.18M in Q1 2025.
- 48 funds tracked by Wall St. Rank held Translational Development Acquisition Corp as of Q1 2026.
Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.